1,516 articles
Robert S. Sherwin
Robert S. Sherwin (1942–2023) was an American endocrinologist who spent 44 years on the Yale faculty, directed its Diabetes Center, and served as president of the American Diabetes Association.
Robert Schwartz (pediatric endocrinologist)
Robert Schwartz is an American physician-scientist in pediatric endocrinology at Brown University and Rhode Island Hospital whose research established how insulin acts in the human fetus and newborn.
Robert V. Farese
Robert V. Farese Jr. is an American biochemist and physician who identified the DGAT enzymes that synthesize triglycerides and helped establish lipid droplets as dynamic organelles.
Robert W. Mahley
Robert W. Mahley is an American physician-scientist who discovered apolipoprotein E, defined its three isoforms, founded the Gladstone Institute of Cardiovascular Disease, and studied apoE4's role in Alzheimer's disease.
Robert W. Wilkins
Robert W. Wilkins was an American physician-scientist in cardiovascular medicine who showed rauwolfia, reserpine, and chlorothiazide could lower high blood pressure, and whose step-care treatment strategy won the 1958 Lasker Award.
Robert W. Yeh
Robert W. Yeh is an interventional cardiologist who directs the Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center and created the DAPT score.
Robert Zelis
Robert Zelis (1939–2021) was an American cardiologist and physician-scientist who spent 40 years at Penn State's Hershey Medical Center, arriving in 1974 as its second chief of cardiology.
Roberto Bolli
Roberto Bolli is an Italian-born American cardiologist and professor at the University of Louisville, known for work on myocardial stunning, ischemic preconditioning, and cardiac stem cells.
Roberto Ferrari (Italian cardiologist)
Roberto Ferrari is an Italian cardiologist, Emeritus Professor at the University of Ferrara, known for leading large trials of ivabradine and trimetazidine and for leading the European Society of Cardiology.
Rocco Vergallo
Rocco Vergallo is an Italian interventional cardiologist at the University of Genoa known for coronary imaging research and his 2020 NEJM review Atherosclerotic Plaque Healing.
Rodney H. Falk
Rodney H. Falk is a British-trained cardiologist who directed the Cardiac Amyloidosis Program at Brigham and Women's Hospital in Boston and is known for his research on cardiac amyloidosis.
Roger Bouillon
Roger Bouillon is a Belgian endocrinologist who spent his career at KU Leuven studying vitamin D and bone metabolism, and led the 2001 Leuven intensive insulin therapy trials.
Roger D. Cone
Roger D. Cone is an American molecular physiologist and neuroscientist known for cloning the melanocortin receptors and showing how the brain's central melanocortin system regulates body weight, work that led to obesity drugs.
Roger Guillemin
Roger Guillemin was a French-born American neuroendocrinologist at the Salk Institute who shared the 1977 Nobel Prize for identifying hypothalamic hormones, isolating thyrotropin-releasing hormone, somatostatin, and endorphins.
Roger H. Unger
Roger H. Unger (1924–2020) was an American endocrinologist and diabetes researcher at UT Southwestern in Dallas, known for the first glucagon radioimmunoassay and the bihormonal hypothesis.
Roger J. Hajjar
Roger J. Hajjar, also known as Roger Hajjar, is an American cardiologist and gene therapy researcher who directs the Gene and Cell Therapy Institute at Mass General Brigham in Boston.
Roger S. Blumenthal
Roger S. Blumenthal is an American cardiologist who directs the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and co-chaired the 2019 ACC/AHA primary prevention guideline.
Roger S. Rittmaster
Roger S. Rittmaster is an endocrinologist known for research on 5α-reductase inhibitors and prostate cancer chemoprevention, who worked at Dalhousie University from 1985 to 1999 and helped design the REDUCE trial at GlaxoSmithKline.
Roland E. Schmieder
Roland E. Schmieder, also known as Roland Schmieder, is a German physician-scientist and professor of hypertension at Universitätsklinikum Erlangen who led the SPYRAL HTN renal denervation trials.
Roland Stocker
Roland Stocker is a Swiss-trained Australian biochemist and vascular biologist who led research at the Heart Research Institute in Sydney, showing that bilirubin acts as an antioxidant and changing neonatal jaundice treatment.
Rolf Luft
Rolf Luft (1914–2007) was a Swedish endocrinologist at the Karolinska Institutet in Stockholm, known for founding mitochondrial medicine and for decades of work on the pathogenesis and treatment of diabetes mellitus.
Rolf M. Gunnar
Rolf M. Gunnar was an American cardiologist known for research on heart attack, cardiogenic shock, and heart failure, and first author of the 1990 ACC/AHA heart attack guidelines.
Roman Hovorka
Roman Hovorka is a Czech-born mathematician and Professor of Metabolic Technology at Cambridge, a world leader in the artificial pancreas whose CamAPS FX app is used by over 27,000 people.
Ron Waksman
Ron Waksman is an interventional cardiologist and researcher at MedStar Washington Hospital Center in Washington, DC, known for developing vascular brachytherapy to treat restenosis in stented arteries.
Ronald A. Arky
Ronald A. Arky is an American endocrinologist specializing in diabetes and metabolism who holds a distinguished professorship at Harvard Medical School and practices in Boston.
Ronald G. Victor
Ronald G. Victor, also known as Ronald Victor, was an American cardiologist and hypertension researcher whose barbershop trials brought blood pressure in Black men under control.
Ronald M. Evans
Ronald M. Evans is an American molecular biologist at the Salk Institute known for discovering the nuclear hormone receptor superfamily, gene-regulating proteins targeted by many drugs.
Rong Tian
Rong Tian is a cardiac metabolism researcher who directs the Mitochondria and Metabolism Center at the University of Washington, studying energetic failure of the heart in heart failure.
Roscoe O. Brady
Roscoe O. Brady (1923–2016) was an American physician-biochemist at NIH who identified the enzyme defects behind Gaucher, Fabry, and Tay-Sachs diseases and developed the first effective enzyme replacement therapy for Gaucher disease.
Rose Marie Robertson
Rose Marie Robertson is an American cardiologist, a Vanderbilt professor who co-founded the first clinic devoted to autonomic disorders, and was American Heart Association president in 2000–2001.